MISOPROSTOL, 25µg, vaginal tab.
STD
DEXTMISP25TV
Valid Article
HS Code:
300439
Last Updated on:
04/02/2025, 22:13:24
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
G02AD06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
MISOPROSTOL 25µg
Therapeutic Action
Oxytocic compound, synthetic analogue of prostaglandin
Indications
Induction of labour
Instructions for use
May be given by oral or vaginal route:
- If oral administration is not possible (e.g., due to vomiting or impaired consciousness), administer by vaginal route.
- Caution! the oral tablet (DORAMISP25T) can be given orally or vaginally. In contrary, the vaginal tablet (DEXTMISP25TV) must only be administered vaginally!
- For vaginal administration:
- to be administered by a healthcare professional (doctor or midwife)
- wash hands carefully.
- remove the tablet from the blister.
- with the patient laying down on a gynaecological examination table, insert the tablet into the posterior fornix of the vagina.
Misoprostol 200 µg can be used as an alternative in case of supply issue with 25 µg dosage. Dissolve 1 tablet of misoprostol 200 µg in 200 ml water and give 25 ml of the dissolved solution (25 ml = 25 µg).
Precautions for Use
- Do not administer in cases of previous caesarean sections.
- Administer with caution in cases of grand multiparity or overdistention of the uterus (risk of uterine rupture).
- Monitor the intensity and frequency of contractions, as well as the foetal heart rate, following misoprostol , following administration.
- Do not administer misoprostol simultaneously with oxytocin.
- Do not use misoprostol in cases of ectopic or molar pregnancy.
Storage
Below 25ºC - Protect from sunlight -Protect from humidity